研討日期

2020316日上午10:20~ 12:30

研討地點

國立臺灣大學609討論室

主講題目

Title of the paper

External Referencing and Pharmaceutical Price Negotiation

作者

Authors of the paper

BEGON˜A GARCIA MARIN˜OSO, IZABELA JELOVAC, and PAU OLIVELLA

文獻出處

Journal, vol.(issue), pp

HEALTH ECONOMICS, 20: 737–756 (2011)

主講人

Dong Van Chung

參加人員

Dong Van Chung、王光正、王羿傑、林燕淑、施全、梁文榮、張瑞雲、彭正浩、黃鴻、周宗翰、BUI DANG LONGLUSUNG MKANDAWIREDAMIANA SIMANJUNTAK、許至乙

摘要

Abstract of the paper

External referencing (ER) imposes a price cap for pharmaceuticals, based on prices of identical or comparable products in foreign countries. Suppose a foreign country (F) negotiates prices with a pharmaceutical firm, whereas a home country (H) can either negotiate prices independently or implement ER, based on the foreign price. We show that country H prefers ER if copayments in H are relatively high. This preference is reinforced when H’s population is small. Irrespective of relative country sizes, ER by country H harms country F. Our model is inspired by the wide European experience with this cost-containment policy. Namely, in Europe, drug authorization and price negotiations are carried out by separate agencies. We confirm our main results in two extensions. The first one allows for therapeutic competition between drugs. In the second one, drug authorization and price negotiation take place in a single agency.